Axios @axios
Pfizer CEO Albert Bourla said his company will know whether its vaccine is effective by the end of October, and that it has manufactured hundreds of thousands of doses in anticipation that it will receive FDA approval. https://t.co/GzoP7Gm465 — PolitiTweet.org